Imatinib mesylate: past successes and future challenges in the treatment of gastrointestinal stromal tumors
{{output}}
Just over a decade ago, gastrointestinal tumours were a poorly understood mesenchymal neoplasm unsuccessfully treated with chemotherapy. Cytotoxic therapy for advanced disease yielded response rates of 10% and median survival of just 18 months. However, the di... ...
